Pages that link to "Q38059739"
Jump to navigation
Jump to search
The following pages link to Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy (Q38059739):
Displaying 15 items.
- Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1 (Q27003153) (← links)
- p53 Family and Cellular Stress Responses in Cancer (Q34377287) (← links)
- Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells (Q35128130) (← links)
- Mitochondrial inhibitor sensitizes non-small-cell lung carcinoma cells to TRAIL-induced apoptosis by reactive oxygen species and Bcl-X(L)/p53-mediated amplification mechanisms (Q36292039) (← links)
- Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein. (Q37596373) (← links)
- MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53. (Q37688946) (← links)
- Chemical and semisynthetic approaches to study and target deubiquitinases. (Q38799376) (← links)
- Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma. (Q41612309) (← links)
- Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway (Q42908737) (← links)
- Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation (Q46792450) (← links)
- Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity (Q47601432) (← links)
- Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a. (Q51129826) (← links)
- Chronic Activation of Gp1 mGluRs Leads to Distinct Refinement of Neural Network Activity through Non-Canonical p53 and Akt Signaling (Q90243427) (← links)
- De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains (Q92643149) (← links)
- The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges (Q95650650) (← links)